ProRelix Research
MAY 23, 2025
As the patents for blockbuster biologics expire, a new era of opportunity emerges, ushering in the rise of biosimilars. These biologic alternatives offer the promise of affordable care, broader global […] The post Open New Markets: How Biosimilar Clinical Trials Drive Access, Profitability, and Global Expansion … appeared first on ProRelix Research.
Bio Pharma Dive
MAY 19, 2025
The biotech, which has for years invested in genetics research, plans to acquire "substantially all" of testing firm 23andMe's assets for $256 million.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MAY 22, 2025
Sanofi has agreed to acquire Vigil Neuroscience in a $470m deal, nearly a year after investing an initial $40m in the company.
pharmaphorum
MAY 22, 2025
The FDA has instructed Pfizer and Moderna to add stronger warnings to the labels of their COVID-19 vaccines about the risk of cardiotoxicity
Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group
Let’s face it—most ethics and compliance training programs aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, captivating, and maybe even enjoyable! Join learning design expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training. We'll explore innovative strategies to bring traditionally dry topics to life, making them resonate with learners and drive tangible change.
Pharma Times
MAY 19, 2025
Regulator confirms safety and efficacy of new treatment option for patient
Bio Pharma Dive
MAY 22, 2025
Still, the therapies’ modest benefit as a maintenance therapy points to how better treatments are needed for small cell lung cancer, according to one physician.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Medical Xpress
MAY 17, 2025
A pharmaceutically produced cannabidiol formulation had a good overall safety profile, including cardiac safety, according to research presented at Heart Failure 2025.
XTalks
MAY 22, 2025
Observed each year on May 24, World Schizophrenia Awareness Day shines a light on one of the most misunderstood mental health conditions. Schizophrenia is a chronic psychiatric disorder that alters how individuals perceive reality, think and relate to others. Symptoms are typically categorized as positive (hallucinations, delusions), negative (emotional withdrawal, social disconnection) or cognitive (memory or attention deficits).
Bio Pharma Dive
MAY 22, 2025
An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K. regulators cleared Sarepta to restart an Elevidys study and Altos Labs bought a startup.
Pharmaceutical Technology
MAY 23, 2025
Genentech has announced an investment exceeding $700m to establish its first East Coast manufacturing facility in North Carolina.
Advertisement
Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness
Medical Xpress
MAY 17, 2025
Researchers at the University of Tsukuba investigated whether monoamine neurotransmitters, such as dopamine, are involved in hippocampal activation even during light exercise. Dopamine secreted from the ventral tegmental area of the brainstem and noradrenaline secreted from the locus coeruleus were hypothesized to be involved in a brain neural circuit that regulates hippocampal activation during light exercise.
pharmaphorum
MAY 22, 2025
Sanofi bids to add a drug candidate for Alzheimer's disease to its neurology pipeline via the acquisition of US biotech Vigil Neuroscience
Bio Pharma Dive
MAY 22, 2025
Tumors with low- and ultra-low levels of a protein called HER2 are treatable with Enhertu, but harder to identify. New research shows AI can improve diagnosis.
Pharmaceutical Technology
MAY 23, 2025
An EMA committee has issued a positive opinion for a label extension that would allow six-month injection intervals for Eylea 8mg.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Medical Xpress
MAY 17, 2025
The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment earlier with newly approved drugs that slow the progression of the devastating neurological disease.
pharmaphorum
MAY 22, 2025
There was good news for Johnson & Johnson at this week's ODAC meetings, but not for Roche, UroGen, and Pfizer
Bio Pharma Dive
MAY 20, 2025
The agency will now require randomized, controlled data before approving new COVID shots for healthy children and adults, Commissioner Martin Makary and top vaccine official Vinay Prasad wrote in NEJM.
Pharmaceutical Technology
MAY 22, 2025
UK biopharmaceutical companies saw a surge in venture financing for innovator drugs in 2024, with double the total deal value from 2022: $827m in 2022 to $1.7bn in 2024.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Medical Xpress
MAY 17, 2025
University of California, Los Angeles and University of California, San Diego researchers developed an injectable sealant for rapid hemostasis and tissue adhesion in soft, elastic organs.
pharmaphorum
MAY 22, 2025
AstraZeneca has turned to another digital health partner to support its aspirations in chronic kidney disease (CKD)
Bio Pharma Dive
MAY 21, 2025
The Swiss pharma has inked several collaborations in this field, suggesting it sees the approach as promising to rid the body of destructive proteins that are hard to target by other means.
Pharmaceutical Technology
MAY 21, 2025
Viz.ai is set to enter into a multi-year collaboration with Sanofi and Regeneron for the management of COPD.
Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk
In today’s complex healthcare environment, navigating third-party relationships has become even more challenging—whether it’s vendor relationships, employee activities, or patient-facing interactions. Left unmanaged, these conflicts can compromise trust, regulatory compliance, and even organizational reputation. So, how can healthcare teams stay ahead?
Pharma Times
MAY 22, 2025
Strategic collaboration aims to improve early diagnosis
pharmaphorum
MAY 23, 2025
Thousands of people living with rare kidney disease IgAN in the UK will soon be able to access a new oral treatment from CSL Vifor
Bio Pharma Dive
MAY 22, 2025
Speaker Mike Johnson negotiated a number of last minute changes to the megabill to get it across the finish line, including moving up the start date for Medicaid work requirements.
Pharmaceutical Technology
MAY 22, 2025
The lower out-of-pocket costs come at a time of governmental scrutiny on prescription drug prices in the US.
Advertisement
Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.
Pharma Times
MAY 22, 2025
The Board of the Medicines and Healthcare products Regulatory Agency (MHRA) has met in Scotland for the first time, marking a significant step in the agencys approach to delivering health and innovation priorities across the UK.
Medical Xpress
MAY 17, 2025
Feel like you can't focus? Like you'll never finish a book again? Like the only way to keep your mind and hands busy is to scroll on social media for hours?
Bio Pharma Dive
MAY 19, 2025
The FDA cleared the test for early detection of amyloid plaques associated with Alzheimer’s in people aged 55 years and older with signs and symptoms of the disease.
Pharmaceutical Technology
MAY 21, 2025
We learn how the EUs new Clinical Trial Regulation (CTR) and the CTIS platform are reshaping clinical trial approvals and the supply chain.
Expert insights. Personalized for you.
52 
Let's personalize your content